|Genetic determination of irritable bowel syndrome|
C Hotoleanu, R Popp, AP Trifa, L Nedelcu, DL Dumitrascu
World journal of gastroenterology: WJG 14 (43), 6636, 2008
|How to diagnose and treat a cancer of unknown primary site.|
C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ...
Journal of Gastrointestinal & Liver Diseases 26 (1), 2017
|Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 ‐1639 G>A polymorphisms in a population from South‐Eastern Europe|
AD Buzoianu, AP Trifa, DF Mureșanu, S Crișan
Journal of cellular and molecular medicine 16 (12), 2919-2924, 2012
|CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study|
C Bănescu, AP Trifa, S Voidăzan, VG Moldovan, I Macarie, ...
Oxidative Medicine and Cellular Longevity 2014, 2014
|Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia|
C Bănescu, AP Trifa, S Demian, E Benedek Lazar, D Dima, C Duicu, ...
BioMed Research International 2014, 2014
|The role of medical registries, potential applications and limitations|
B Pop, B Fetica, ML Blaga, AP Trifa, P Achimas-Cadariu, CI Vlad, ...
Medicine and pharmacy reports 92 (1), 7, 2019
|TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms …|
AP Trifa, C Bănescu, M Tevet, A Bojan, D Dima, L Urian, T Török‐Vistai, ...
British Journal of Haematology 174 (2), 218-226, 2016
|MECOM, HBS1L‐MYB, THRB‐RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients|
AP Trifa, C Bănescu, AS Bojan, CM Voina, Ș Popa, S Vișan, AD Ciubean, ...
American Journal of Hematology 93 (1), 100-106, 2018
|The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms|
AP Trifa, A Cucuianu, L Petrov, L Urian, MS Militaru, D Dima, IV Pop, ...
Annals of hematology 89, 979-983, 2010
|Prevalence of the c. 35delG and p. W24X mutations in the GJB2 gene in patients with nonsyndromic hearing loss from North-West Romania|
C Lazăr, R Popp, A Trifa, C Mocanu, G Mihut, C Al-Khzouz, E Tomescu, ...
International journal of pediatric otorhinolaryngology 74 (4), 351-355, 2010
|From six gene polymorphisms of the antioxidant system, only GPX Pro198Leu and GSTP1 Ile105Val modulate the risk of acute myeloid leukemia|
C Bănescu, M Iancu, AP Trifa, M Cândea, E Benedek Lazar, ...
Oxidative Medicine and Cellular Longevity 2016, 2016
|Vitamin D receptor polymorphisms and melanoma|
AF Vasilovici, LE Grigore, L Ungureanu, O Fechete, E Candrea, AP Trifa, ...
Oncology Letters 17 (5), 4162-4169, 2019
|XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia|
C Bănescu, C Duicu, AP Trifa, M Dobreanu
Leukemia & lymphoma 55 (2), 365-370, 2014
|Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome|
A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ...
Critical Reviews in Clinical Laboratory Sciences 55 (7), 501-515, 2018
|An acenocoumarol dose algorithm based on a South-Eastern European population|
TR Pop, ȘC Vesa, AP Trifa, S Crișan, AD Buzoianu
European journal of clinical pharmacology 69, 1901-1907, 2013
|Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population|
C Bănescu, M Iancu, AP Trifa, M Dobreanu, VG Moldovan, C Duicu, ...
Tumor Biology 37, 9357-9366, 2016
|The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential …|
AP Trifa, A Cucuianu, RA Popp, CA Coadă, RM Costache, MS Militaru, ...
Annals of hematology 93, 203-209, 2014
|Phytochemicals in cardiovascular and respiratory diseases: Evidence in oxidative stress and inflammation|
RM Pop, A Popolo, AP Trifa, LA Stanciu
Oxidative Medicine and Cellular Longevity 2018, 2018
|The impact of the CYP2C9 and VKORC1 polymorphisms on acenocoumarol dose requirements in a Romanian population|
AD Buzoianu, FC Militaru, ȘC Vesa, AP Trifa, S Crișan
Blood Cells, Molecules, and Diseases 50 (3), 166-170, 2013
|2016 WHO clinical molecular and pathological criteria for classification and staging of myeloproliferative neoplasms (MPN) caused by MPN driver mutations in the JAK2, MPL and …|
JJ Michiels, M Tevet, A Trifa, E Niculescu-Mizil, A Lupu, AM Vladareanu, ...
Maedica 11 (1), 5, 2016